Lazard Asset Management LLC purchased a new position in shares of IMAX Co. (NYSE:IMAX) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,000 shares of the company’s stock, valued at approximately $215,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of IMAX. First Trust Advisors LP raised its holdings in IMAX by 73.0% during the first quarter. First Trust Advisors LP now owns 38,383 shares of the company’s stock worth $871,000 after purchasing an additional 16,201 shares in the last quarter. Swiss National Bank grew its position in IMAX by 1.0% during the first quarter. Swiss National Bank now owns 114,400 shares of the company’s stock worth $2,299,000 after buying an additional 1,100 shares during the period. BlackRock Inc. grew its position in IMAX by 12.3% during the first quarter. BlackRock Inc. now owns 3,109,955 shares of the company’s stock worth $62,509,000 after buying an additional 341,440 shares during the period. HighTower Advisors LLC acquired a new position in IMAX during the first quarter worth about $278,000. Finally, JPMorgan Chase & Co. grew its position in IMAX by 230.5% during the first quarter. JPMorgan Chase & Co. now owns 176,965 shares of the company’s stock worth $3,557,000 after buying an additional 123,422 shares during the period. 74.08% of the stock is owned by hedge funds and other institutional investors.
Shares of IMAX stock opened at $20.60 on Thursday. The company’s fifty day simple moving average is $16.76 and its 200-day simple moving average is $19.21. IMAX Co. has a 52 week low of $10.65 and a 52 week high of $25.05. The company has a market cap of $1.22 billion, a PE ratio of -13.12 and a beta of 1.77.
IMAX has been the topic of several recent analyst reports. TheStreet lowered shares of IMAX from a “c-” rating to a “d+” rating in a research report on Thursday, July 29th. Colliers Securities reiterated a “buy” rating and issued a $22.00 price target on shares of IMAX in a research report on Monday, July 26th. Barrington Research lowered their price target on shares of IMAX from $27.00 to $22.00 and set an “outperform” rating on the stock in a research report on Thursday, July 29th. Wedbush restated a “buy” rating and set a $26.00 target price on shares of IMAX in a research report on Wednesday, August 11th. Finally, B. Riley raised their target price on shares of IMAX from $28.00 to $30.00 and gave the stock a “buy” rating in a research report on Monday. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $24.06.
IMAX Corp. is an entertainment technology company, which engages in the business of motion picture technologies and presentations. It operates through following four business segments: IMAX Technology Network; IMAX Technology Sales and Maintenance; New Business Initiatives; and Film Distribution and Post-Production.
Featured Article: What is the accumulation/distribution indicator?
Want to see what other hedge funds are holding IMAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMAX Co. (NYSE:IMAX).
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.